Yin Li

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Bioavailable testosterone reduces the risk of lung squamous cell carcinoma: a comprehensive data study.

Bioavailable testosterone reduces the risk of lung squamous cell carcinoma: a comprehensive data study.

Journal: Journal of translational medicine
Published: July 28, 2025

Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways.

Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways.

Journal: Drugs in R&D
Published: September 18, 2023

Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic Leukemia.

Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic Leukemia.

Journal: Current medical science
Published: May 24, 2023

Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma.

Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma.

Journal: Cell death discovery
Published: September 03, 2021

Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.

Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.

Journal: Clinical epigenetics
Published: February 18, 2019

Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathway.

Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathway.

Journal: European journal of pharmacology
Published: June 29, 2018

The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.

The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.

Journal: Targeted oncology
Published: July 16, 2017

Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.

Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.

Journal: Clinical epigenetics
Published: January 11, 2017

Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.

Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.

Journal: Oncotarget
Published: June 30, 2016

Effective elimination of adult B-lineage acute lymphoblastic leukemia by disulfiram/copper complex in vitro and in vivo in patient-derived xenograft models.

Effective elimination of adult B-lineage acute lymphoblastic leukemia by disulfiram/copper complex in vitro and in vivo in patient-derived xenograft models.

Journal: Oncotarget
Published: January 06, 2016

A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor.

A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor.

Journal: Current cancer drug targets
Published: August 19, 2015

Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftments.

Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftments.

Journal: Journal of hematology & oncology
Published: February 17, 2015
Showing 1-12 of 14

Last Updated: 09/26/2026